| Medical and Health Sciences | 2021-2025 | 314 | SE 6 | 99.94 |
| Cardiology and Cardiovascular Medicine | Lifetime | 259 | SE 5 | 99.66 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 645 | SE 12 | 97.89 |
| Nephrology | Lifetime | 567 | SE 11 | 93.50 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 107 | SE 2 | 99.48 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 228 | SE 6 | 95.77 |
| Surgery | 2021-2025 | 741 | SE 15 | 93.48 |
| Epidemiology | 2021-2025 | 730 | SE 8 | 92.82 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 678 | SE 8 | 91.68 |
| Blood Pressure and Hypertension Studies | Lifetime | 102 | SE 3 | 99.59 |
| Cardiovascular Function and Risk Factors | Lifetime | 291 | SE 6 | 99.44 |
| GDF15 and Related Biomarkers | Lifetime | 35 | SE 4 | 97.35 |
| Cardiovascular Health and Disease Prevention | Lifetime | 326 | SE 4 | 98.40 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 452 | SE 16 | 98.48 |
| Heart Failure Treatment and Management | Lifetime | 524 | SE 19 | 98.06 |
| Protease and Inhibitor Mechanisms | Lifetime | 400 | SE 12 | 97.45 |
| Cardiac Fibrosis and Remodeling | Lifetime | 246 | SE 2 | 96.45 |
| Diabetes Treatment and Management | Lifetime | 840 | SE 30 | 97.17 |
| Hormonal Regulation and Hypertension | Lifetime | 844 | SE 24 | 96.81 |
| Cardiovascular Disease and Adiposity | Lifetime | 907 | SE 28 | 95.85 |
| Chronic Kidney Disease and Diabetes | Lifetime | 735 | SE 12 | 96.18 |
| Sodium Intake and Health | Lifetime | 352 | SE 5 | 94.84 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 34 | SE 1 | 99.13 |
| Heart Failure Treatment and Management | 2021-2025 | 226 | SE 7 | 97.31 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 279 | SE 6 | 93.60 |
| Hormonal Regulation and Hypertension | 2021-2025 | 245 | SE 5 | 91.75 |
| Acute Myocardial Infarction Research | 2021-2025 | 671 | SE 17 | 92.45 |
| Diabetes Treatment and Management | 2021-2025 | 836 | SE 21 | 91.72 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 557 | SE 13 | 88.94 |
| Cardiovascular Syncope and Autonomic Disorders | 2021-2025 | 376 | SE 8 | 79.92 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 786 | SE 8 | 78.32 |
| Sodium Intake and Health | 2021-2025 | 338 | SE 1 | 77.99 |
| Alcohol Consumption and Health Effects | 2021-2025 | 986 | SE 20 | 75.14 |
| Potassium and Related Disorders | 2021-2025 | 737 | SE 28 | 59.55 |
| GDF15 and Related Biomarkers | 2021-2025 | 647 | SE 27 | 52.68 |